Opinion|Videos|November 30, 2023
How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
How New Therapies Are Changing the Game for Small Cell Lung Cancer
2
Sac-TMT Combo Shows Benefit in Advanced Lung Cancer Treatment
3
SANRECO Trial Explores Divesiran for Polycythemia Vera Treatment
4
How I Navigate Grief and the Holidays After Cancer Loss
5
